Antifungal activity of dihydrobenzofuran neolignans
暂无分享,去创建一个
[1] J. Guarner. Human immunodeficiency virus and fungal infections. , 2017, Seminars in diagnostic pathology.
[2] Alexandra Flemming. Fungal infection: JNK inhibitors boost antifungal immunity , 2017, Nature Reviews Immunology.
[3] M. Hung,et al. JNK1 negatively controls anti-fungal innate immunity by suppressing CD23 expression , 2017, Nature Medicine.
[4] D. Denning,et al. The burden of serious human fungal infections in Brazil , 2016, Mycoses.
[5] C. Yenjai,et al. Canangalias A and B from the stem bark of Cananga latifolia , 2015 .
[6] D. Jain,et al. Chalcone derivatives as potential antifungal agents: Synthesis, and antifungal activity , 2015, Journal of advanced pharmaceutical technology & research.
[7] T. Kar,et al. Detailed 1H and 13C NMR Spectral Data Assignment for Two Dihydrobenzofuran Neolignans , 2015 .
[8] K. Ferreira-Paim,et al. Identification and antifungal susceptibility of fungi isolated from dermatomycoses , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.
[9] Juntao Feng,et al. Synthesis, Antifungal Activities and Qualitative Structure Activity Relationship of Carabrone Hydrazone Derivatives as Potential Antifungal Agents , 2014, International journal of molecular sciences.
[10] Sen Liu,et al. Cytotoxic and antioxidant dihydrobenzofuran neolignans from the seeds of Crataegus pinnatifida. , 2013, Fitoterapia.
[11] J. Meis,et al. Current Management of Fungal Infections , 2012, Drugs.
[12] J. Gantier,et al. Epidemiology of superficial fungal diseases in French Guiana: a three-year retrospective analysis. , 2011, Medical mycology.
[13] M. Ameen,et al. Epidemiology of superficial fungal infections. , 2010, Clinics in dermatology.
[14] F. Koksal,et al. Causative Agents of Superficial Mycoses in Istanbul, Turkey: Retrospective Study , 2009, Mycopathologia.
[15] M. Friedrich,et al. Epidemiological trends in skin mycoses worldwide , 2008, Mycoses.
[16] C. Nakamura,et al. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes. , 2008, Journal of ethnopharmacology.
[17] L. Nahar,et al. Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals , 2007, Methods.
[18] C. Nakamura,et al. Antifungal activity of the extracts and neolignans from Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Yunck , 2005 .
[19] L. Pieters,et al. Antileishmanial activity, cytotoxicity and QSAR analysis of synthetic dihydrobenzofuran lignans and related benzofurans. , 2005, Bioorganic & medicinal chemistry.
[20] S. Apers,et al. Lignans and neolignans as lead compounds , 2004, Phytochemistry Reviews.
[21] E. Yoo,et al. In vitro antiinflammatory effects of neolignan woorenosides from the rhizomes of Coptis japonica. , 2000, Journal of natural products.
[22] L. Pieters,et al. Synthesis and biological evaluation of dihydrobenzofuran lignans and related compounds as potential antitumor agents that inhibit tubulin polymerization. , 1999, Journal of medicinal chemistry.
[23] Y. Kuo,et al. Synthesis of 5-(3-hydroxypropyl)-7-methoxy-2-(3'-methoxy-4'-hydroxyphenyl)-3-benzo[b]furancarbaldehyde, a novel adenosine A1 receptor ligand from the root of Salvia miltiorrhiza , 1996 .
[24] H. Masuda,et al. Studies on the preparation of bioactive lignans by oxidative coupling reaction. III. Synthesis of polyphenolic benzofuran and coumestan derivatives by oxidative coupling reaction of methyl (E)-3-(4-hydroxy-2-methoxyphenyl)propenoate and their inhibitory effect on lipid peroxidation. , 1994, Chemical & pharmaceutical bulletin.
[25] O. Gottlieb. The rational search for natural neolignans. , 1991, Memorias do Instituto Oswaldo Cruz.